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The pathologic spedmens (n = 118) and hospital course 
pertinent to each of 62 adult liver allograft recipients were 
reviewed. Biopsies and retransplanted organs were ob-
tained at the discretion of the surgical team on the basis 
of the postoperative clinical course «1 day to >12 years 
after transplantation), and final interpretation of the 
pathologi.:: material was based on a correlation of all avail-
able data. Most of the specimens (n = 8?) were obtained 
within the first 2 months, and diagnoses in this time period 
included rejection, biliary obstruction/cholangitis, vas-
cular injury, herpesvirus and cytomegalovirus hepatitis, 
graft necrosis, and functional cholestasis. Thereafter, re-
jection and recurrent or primary viral hepatitis were the 
RECOGNITION of rej~ction and other hepatic com-
plications by needle biopsy can playa significant role 
in the management of liver allograft recipients. 1-3 Clin-
ically. the diagnosis of rejection is difficult and is often 
made by the exclusion of other causes of graft dysfunc-
tion. Discrepancies exist, however, in the histologic 
description of rejection, particularly in reference to the 
appearance of acute and chronic forms and the extent 
of involvement of small interlobular bile ductules.I-5.9.IO 
Moreover, description of other hepatic complica-
tions6- lo and recurrent disease8 •11 is limited. 
The following is a review of hepatic pathology in 62' 
adult liver allograft recipients maintained on cyclospo-
rine/steroid immunosuppression. The report is based 
upon a review of all the needle biopsies, failed allografts, 
and autopsy specimens from these patients. The histo-
logic recognition of rejection and its separation from 
other hepatic complications and recurrent disease is dis-
cussed and correlated with the clinical data. 
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major causes of graft dysfunction. Histologically, hepatic 
rejection is manifested by a cellular mediated injury of 
hepatocytes and bile ductules and a spectrum of vascular 
lesions in medium-sized hilar arteries. Morphologic 
changes of biliary duct obstruction and viral liver dis-
ease were at times difficult to differentiate from rejection. 
Two pretransplant disorders, type B viral hepatitis and 
the Budd-Chiari syndrome, recurred in grafted organs. 
Although interpretation of pathologic material may be 
difficult at times, it frequently is helpful in planning an 
approach to management of liver allograft recipients. 
(Am J Pathol 1985, 118:151-161) 
Materials and Methods 
Case Selection 
Patients were selected on the basis that at least one 
posttransplant liver specimen were available for patho-
logic review. The population consisted of 30 males and 
32 females with an average age of 33 years (range, 16-58 
years) who underwent transplants from 1972 to 1981 
at Denver (4 patients) and from 1981 to the present at 
the University of Pittsburgh (58 patients). 
Accepted for publication August 23, 1984. 
Address reprint requests to Andrew Dekker, MD, Depart-
ment of Pathology. Presbyterian University Hospital, DeSoto 
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Table 1 -Summary of Histologic Findings in Specimens 
With Rejection 
Total specimens 
Portal inflammation 
Disruption of limiting plate 
Bile ductular injury t 
Centrilobular necrosis 
Centrilobular intlammation:j: 
Cholestasis 
• After transplantation. 
<2 Months 
post-Tx' (%) 
21 (100) 
Moderate-severe 
(100) 
5 (24) 
9 (43) 
18 (86) 
19 (90) 
Moderate (100) 
>2 Months 
post-Tx' (%) 
15 (100) 
Mild-Moderate 
(100) 
11 (73) 
12 (80) 
7 (47) 
7 (47) 
Mild-Moderate 
(73)§ 
t Paranuclear vacuolization, cytoplasmic eosinophilia, nuclear pykno-
sis, inflammatory-cell infiltration, or 1055 of bile ductules. 
1= Large lymphocytes in the center of the lobule and/or infiltrating the 
subendothelial space of terminal hepatic (central) veins. 
§ The remaining specimens had minimal or no cholestasis. 
Pathologic Material and Review 
A total of 118 specimens were reviewed, which in-
cluded 71 needle biopsies, 26 surgically removed al-
lografts, and 21 autopsies. Surgical specimens ranging 
from less than 30 minutes to greater than 12 years after 
transplantation were obtained at the discretion of the 
surgical team. All slides were routinely stained with 
hematoxylin and eosin (H&E), reticulin, and trichrome. 
Special stains were utilized when appropriate and in-
cluded orcein, rhodamine, iron, elastin, and the im-
munoperoxidase technique12 for hepatitis B surface and 
core antigen and herpes simplex. The slides were 
reviewed once blindly and a second time with clinical 
information available. 
Clinical Review and Final Diagnosis 
Hospital charts were reviewed; and the hospital course 
pertinent to each specimen, including radiographic, en-
doscopic, and surgical procedures, along with labora-
tory data, medications, and clinical impressions, was 
recorded. A final diagnosis for each specimen was made 
after a correlative review of both the pathologic and 
clinical material. 
Operative Procedure and Immunosuppression 
All operative procedures were orthotopic allograft 
transplantations with end-to-end vascular anastomo-
sis of all pre- and post-hepatic vessels. The majority 
of the biliary anastomoses were choledochocholedo-
chostomies or Roux-en-Y choledochojejunostomies, 
both with donor cholecystectomy. 
The immunosuppression protocol in 58 of the 62 pa-
tients studied consisted of a loading dose of cyclospo-
rine (17.5 mg/kg/day) given just prior to surgery, fol-
. AJP • January 1985 
lowed by a maintenance dose of 10 mg/kg/day. This 
was combined with steroids at an initial dose of 200 
mg/day prednisone, which was tapered rapidly to 40 
mg/day and then gradually to a maintenance dose of 
10-20 mg/day. Suspected rejection was treated with sup-
plemental steroids generally given as a log bolus of Solu-
cortef (U pjohn) on alternate days. 
Histopathology 
Rejection 
Results 
Rejection was the primary process in 36 of the 118 
specimens examined. This diagnosis was never made 
before 6-7 days after transplantation, occurred com-
monly within the first 2 months, but could be seen any 
time thereafter. In early (less than 2 months) episodes 
of rejection (see Table I), a moderate to severe inflam-
matory infiltrate expanded the portal tracts (Figure la). 
It consisted of large and plasmacytoid lymphocytes with 
occasional mitotic figures, macrophages, and smalllym-
phocytes with fewer polymorphonuclear leukocytes and 
eosinophils. These cells occasionally spilled into the pe-
riphery of the lobule and were associated with periportal 
hepatocyte necrosis (5 of 21 specimens). Inflammatory 
cells were also seen in and around the central veins (19 
of 21 specimens) and to a much lesser degree permeat-
ing through the sinusoids and space of Disse. Branches 
of the portal veins within the portal tracts contained 
subendothelial inflammatory cells and frequently had 
a hyperplastic and focally disrupted endothelium (Fig-
ure Ib). Fibrin in the portal tracts was frequently 
deposited in a concentric fashion around the veins. 
Small bile ductules generally showed hyperplastic 
changes; however, ductular cell damage as evidenced 
by inflammatory-cell infiltration, paranuclear vacuoli-
zation, nuclear pyknosis, cytoplasmic eosinophilia, mi-
toses, dysplasia, or luminal disruption was present in 
9 of 21 specimens (Figure Id). Changes in the small ar-
terioles included intimal sclerosis and hyperplasia, 
thickening, and eosinophilia, evaluation of which was 
quite subjective. Alterations in the terminal hepatic 
(central) veins (Figure Ie) were identical to those de-
scribed for portal veins except for the degree of inflam-
mation, which was generally less. A moderate degree 
of canalicular and hepatocellular bile stasis was pres-
ent in Zone 3 and occasionally also in Zone 2 (of Rap-
paport) in all specimens with rejection (less than 2 
months). These changes were accompanied by varying 
degrees of centrilobular necrosis (18 of 21), reticulin col-
lapse with central-to-central linkage (2 of 21) (Figure 
Ie), centrilobular inflammation (19 of 21 specimens) 
similar in nature to that prtsent in portal tracts, and 
hemorrhage. In more severe examples (2 specimens) the 
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Figure 1- Rejection. a - Retransplant specimen from OLT 310, 58 days after transplantation. Note the prominent inflammatory infiltrate 
In the portal tract (PT) and centrilobular region (CL). (H&E, x 100) b- High-power photograph of the portal tract from a. Note the infiltration of 
the portal vein (PIf) by inflammatory (arrow) cells and diffuse portal infiltrate obscuring bile ductules. (H&E, x 250) c - High-power photograph 
of centrilObular region from a. Note the subendothelial inflammatory cells (arrow) in the central vein (CIf) and hemorrhage (Hem). (H&E, x 250) 
d-RetransPlant specimen from OLT 225.19 days after transplantation. Note the inflammatory-cell infiltration and disruption of the bile ductuiar 
lumen and changes indicative of biliary epithelial cell damage (arrows). (H&E, x 250) e-Retransplant specimen from OLT 339. 9 days 
after transplantation Note the centrilobular reticulin collapse with central-to-central bridging. (Reticulin stain. x 100) f - Needle biopsy 
. Specimen from OLT 181,1 year after transplantation showing diffuse portal tract inflammation with spillover into lobule (small arrow) and 
lack of recognizable bile ductule. The portal vein contains subendothelial inflammatory cells (large arrow). (H&E, x 250) 
... --------------------------------
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inflammatory infiltrate increased in intensity and in the 
relative number of polymorphonuclear leukocytes. In 
addition, in these 2 cases of severe rejection, bile duc-
tular cell proliferation was more prominent, as well as 
centrilobular necrosis, hemorrhage, and reticulin col-
lapse. As the rejection episode abated, as a consequence . 
of bolstered immunosuppression, the inflammatory 
infiltrate subsided, leaving a mild residual thickening 
of the portal and terminal hepatic (central) veins and 
a mild to moderate degree of centrilobular cholestasis 
and portal fibrosis. 
Early rejection episodes (within the first 2 months) 
appeared to have the most intense inflammatory 
infiltrate, whereas subsequent episodes (greater than 2 
months after transplant) were generally less severe but 
on occasion could also be quite severe. Although simi-
lar in composition, the inflammatory infiltrate in cases 
of rejection greater than 2 months appeared less intense 
in portal tracts and frequently was absent from the cen-
trilobular areas. Specimens obtained later than 2 
months after transplantation (Figure If) were also 
characterized by the presence of more prevalent disrup-
tion of the limiting plate (11 of 15 specimens), bile duc-
tular injury (12 of 15), and centrilobular hepatocellu-
lar atrophy. Cholestasis and centrilobular necrosis (7 
of 15 specimens) were much less prevalent. This histo-
logic appearance was similar to that seen in chronic per-
sistent or active liver disease. In these particular speci-
mens immunoperoxidase studies for hepatitis B-related 
antigens were performed and found to be negative, 
which ruled out primary or recurrent B viral infection. 
Bile ductular damage. and venous subendothelial 
infiltration were prominent in these specimens. 
Moreover, several of the patients with this change had 
a prompt biopsy-proven-histopathologic response to 
bolstered immunosuppression. A summary of these 
histologic findings is shown in Table 1. 
In patients experiencing several episodes of rejection, 
over a period of time there was a decrease in the num-
ber of small interlobular bile ductules (5 patients). Al-
though this finding was focal and nonquantitative, it 
was commonly associated with a remarkably high se-
rum level of gammaglutamyl transpeptidase (GGTP) 
in the absence of clinically documented large-duct 
obstruction. 
Arterial Alterations in Rejection 
The arterial lesions of rejection (Figure 2a-d) were 
most recognizable in medium-sized hilar arteries and 
therefore better appreciated in retransplant and autopsy 
specimens than in biopsy specimens. Acute arterial le-
sions were seen within the first 2 months after trans-
plantation and included inflammatory-cell infiltration 
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(vasculitis) consisting oflymphocytes and macrophages 
with disruption of the elastic lamina and fibrinoid 
necrosis. 
Chronic arterial lesions were seen usually later than 
4 months after transplantation and included deposi-
tion of subintimal foam cells, intimal sclerosis, and my-
ointimal hyperplasia. These alterations often led to 
significant narrowing or complete occlusion of these 
arteries. A summary of the vascular lesions is presented 
in Table 2. 
Two of the 36 specimens with rejection (11 and 144 
months after transplantation) had significant chronic 
arterial lesions and only a mild to moderate pa-
renchymal inflammatory infiltrate. Usually, however, 
both arterial and parenchymal lesions were present 
simultaneously. 
One liver removed 12 years after transplantation had 
significant narrowing of the hepatic arteries secondary 
to subintimal foam cells and niyointimal hyperplasia 
(Figure 2d). There was only a scant inflammatory 
infiltrate in the portal tracts. Terminal hepatic (central) 
and portal veins were mildly thickened, and in addi-
tion there was sub sinusoidal and moderate portal fibro-
sis indicative of earlier rejection episodes. PortaI-to-
portal and portal-to-central linkage by thin fibrous 
bands associated with an intralobular regenerative 
nodularity was also present. Many portal tracts were 
entirely devoid of small bile ductules, and curiously 
some of these same portal tracts were free of inflam-
mation. Centrilobular hepatocytes were atrophic, which 
resulted in an apparent widening of the sinusoids. Foam 
cells similar to those seen in the hilar arteries were pres-
ent (occasionally in small clusters) within the sinusoids. 
As indicated above, the changes noted in the small in-
terlobular portal arterioles were rather subjective and 
consisted of intimal sclerosis and medial thickening with 
eosinophilia, findings which may not be reliable for the 
diagnosis of chronic vascular lesions of rejection in the 
absence of clinical data ruling out other causes for graft 
injury or failure. 
Viral Liver Disease 
There were 2 cases of recurrent type B viral hepati-
tis, with one leading to cirrhosis. The histologic appear-
ance of viral hepatitis in this setting (Figure 3a) was 
not dissimilar to that seen in nonallograft livers and 
was characterized by a greater degree of lobular disar-
ray, hepatocyte ballooning, and individual hepatocyte 
necrosis throughout the lobule when compared with 
those in which rejection was the primary process. In 
addition, the inflammatory infiltrate in these cases of 
recurrent viral disease appeared to extend a greater dis-
tance from portal tracts into the lobule and to surround 
individual or clusters of hepatocytes (i.e., piecemeal 
" l' 
I 
.. 
Vol. 118 • No. 1 HL;'\ j ,;, TRANSPLANTATION 155 
Figure 2 - Vascular alterations of rejection, a - Retransplant specimen from OLT 31,58 days after transplantation showing fibrinoid necrosis 
of medium·sized hilar artery. (H&E, x 250) b - Retransplant specimen from OL T 212, 8 months after transplantation, showing a thickened 
branch of hepatic artery (HA) with deposition of foam cells in media, (H&E, x 100) c - Same specimen as in b showing subintimal foam 
cells narrowing a hilar artery, (H&E, x 100) d-Retransplant specimen from OLT 56,12 years after transplantation, showing myointimal 
hyperplasia of the hilar artery. 
necrosis) and contained fewer large lymphocytes. Con-
versely, inflammatory cell infiltration and disruption of 
the venous subendothelium and bile ductular destruc-
tion was much less conspicuous. All diagnoses of recur-
rent viral disease were confirmed by the immunoperox-
idase technique for core (HBcAg) and/or surface. 
(HGsAg) antigens. 
There was one case of herpes simplex Type I hepati-
tis characterized by well-demarcated areas of confluent 
necrosis which was not confined to the limits of the 
lobular architecture. These areas contained nuclear 
Cowdry type A inclusions, multinucleated giant cells 
and an inflammatory cell infiltrate with abundant poly-
morphonuclear leukocytes. 
Four cases of cytomegalovirus (CMV) hepatitis were 
seen, and two patterns of hepatic involvement were 
noted. In the first, small collections (microabscesses or 
microgranuloma) of inflammatory cells (predominantly 
polymorphonuclear leukocytes or a mixed infiltrate) 
were present randomly throughout the lobule, some of 
which surrounded hepatocytes containing nuclear 
andlor cytoplasmic inclusions typical of CMV (Figure 
3b). The portal areas of these same livers were relatively 
free of inflammatory cells, therefore providing little evi-
dence for the presence of coexistent rejection. The sec-
ond pattern of CMV involvement was much more ex-
tensive, with numerous inclusion-bearing cells, which 
were noted predominantly in the portal vein en-
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Table 2 - Summary of Vascular Alterations in Rejection * 
Time after transplant (weeks) 
1-4 4-8 8-26 26-52 >52 
---
No. % No. % No. % No. % No. % 
Total number retransplanted livers with rejection 6 100 6 100 3 100 100 2 100 
Subintimal foam cells 4 67t 4 67t 3 100 1 100 2 100 
Fibrinoid necrosis 1 17 2 33 33 a '0 
Vasculitis 1 17 2 33 1 33 a 0 
Myointimal hyperplasia a a a 0 50* 
• Based on retransplant specimens with rejection (n = 18) as the primary process. 
t Accumulations were much less than those found in later specimens. 
t From OL T 56 12 years after transplantation. 
dothelium, small bile ductules, and periportal hepato-
cytes. Although inclusion-bearing cells were distributed 
randomly throughout the lobule and were often sur-
rounded by inflammatory cells as described above, there 
also was a prominent lymphocytic infiltrate in the por-
tal tracts and centrilobular regions identical to that seen 
in rejection (Figure 3c). This latter pattern followed the 
former in two cases, 3 and 4 days after a decrease of 
immunosuppressive therapy. 
Graft Necrosis 
Massive subtotal or total graft necrosis was present 
in 5 specimens (4 autopsies, 1 surgical retransplant). In 
only one instance could this finding be attributed to 
postmortem autolysis. In two of the four others vascu-
lar compromise appeared to be the responsible factor. 
Changes of severe rejection were present in remaining 
viable liver in the two other cases. Blood and liver cul-
tures from these later two patients were positive for 
gram-negative organisms. A similar relationship be-
tween graft rejection, graft necrosis, and gram-negative 
infection was reported by Starzp3 in the pre-CyA era 
and has been termed "septic hepatic gangrene." 
Functional Cholestasis 
There were 8 specimens in which the only histologic 
finding was moderate to severe centrilobular hepatocel-
lular and canalicular cholestasis. The portal tracts of 
these livers were relatively free of an inflammatory 
infiltrate, which suggests cell-mediated injury as an un-
likely cause of graft dysfunction. Clinically, all of these 
patients had a significant elevations of serum bilirubin 
(30-40070 indirect fraction), coagulopathy, and no evi-
dence of large duct obstruction. Medication regimens 
in these patients were not significantly different from 
the others, and response to bolstered immunosuppres-
sion was disappointing. 
Biliary'Obstruction, Cholangitis, and Vascular Injury 
Hepatic pathology secondary to bilary obstruc-
tion,14-16 cholangitis,17.18 and hepatic vascular injury l9.10 
occurred most commonly in the first 1-2 months and 
were histologically identical to that reported to OCCur 
in nonallografts. Septic cholangitis, however, was more 
frequent in those patients with biliary tract infection 
prior to transplantation. 
Nonspecific Changes 
Mild histologic alterations were present in many of 
the tissue specimens examined to which no specific eti-
ology could be ascribed. These changes included mild 
portal tract edema, lymphatic and portal vein dilation, 
Kuppfer-cell activation, two-cell-thick hepatic plates, 
and mild centrilobular cholestasis. 
Clinical Pathologic' Correlative Review 
Causes of graft dysfunction were often difficult to 
determine from clinical parameters alone, and the di-
agnosis of rejection was often made by exclusion. Like-
wise, interpretation based on biopsy histology alone, 
although somewhat more reliable, was also limited. 
However, when all available information was consid-
ered, etiologic factors could be identified in a large 
majority of cases. During the early postoperative period 
(the first 2-3 months) most causes of graft dysfunction 
were attributable to biliary tract obstruction, cholan-
gitis, vascular insults, and rejection (see Table 3). Patho-
logically, in this time period biliary tract disorders were 
at times difficult to differentiate from rejection; there-
fore for substantiation of the diagnosis, results of 
studies of biliary tract patency (cholangiography, ab-
dominal ultrasonography, etc.) and bile cultures (when 
available) were examined. 
The differential diagnosis of specimens obtained in 
later (>2 months) instances of graft dysfunction both 
clinically and pathologically included recurrent or pri-
mary viral liver disease, recurrent original disease, and 
rejection. Differentiation was particularly difficult when 
the biopsy showed a chronic active or persistent liver 
disease histology. In addition to biliary tract studies 
(above), ~m arteriogram showing diffuse narrowing of 
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Figure 3-Viral hepatitis. a- Needle biopsy specimen from OLT 
195,10 months atter transplantation, with recurrent hepatitis B. Note 
the ballooning of hepatocytes, lobular "disarray," and extenSion of 
infiltrate into the lobule. (H&E, x100; inset, x250) b-Needle 
biopsy specimen from OL T 336, 27 days after transplantation, with 
CMV hepatitis. Note the few necrotic hepatocytes with inclusions 
(arrow) surrounded by polymorphonuclear leukocytes. The portal 
tracts were free of an inflammatory infiltrate. (H&E, x 250) c-
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the hepatic arterial tree, negative hepatitis serologic tests 
negative immunoperoxidase tissue staining (viral anti-
gens), significant elevations of GGTP in the. absence 
of large-duct obstruction, careful histologic examina-
tion (see histopathology), and prompt response to bol-
stered immunosuppression were helpful but not abso-
lute distinguishing features of rejection in such cases. 
Cause of Graft Failure 
Only livers removed at retransplantation were con-
sidered as failed grafts. Autopsy specimens were ex-
cluded from this analysis because of frequent com-
plicating clinical circumstances surrounding the 
patient's demise which made determination of graft via-
bility difficult. The causes of graft failure as a function 
of time after transplantation are shown in Table 4. Most 
graft failures (20 of 26 specimens) occurred early within 
the first 2 months following transplantation, and those 
which were due to technical complications (8 of 26 spec-
imens) occurred within the first 4 weeks. Thereafter, re-
jection accounted for 11 of the 12 graft failures neces-
sitating retransplantation. 
Incidence of Rejection 
No precise statement as to the incidence of rejection 
can be made from this study because pathologic mate-
rial available for evaluation came from only 62 of the 
95 adult patients undergoing transplantation at Pitts-
burgh, and suspected rejection was treated without liver 
biopsy in many cases. Nevertheless, in the Pittsburgh 
experience, in 35 patients sampled, rejection was pres-
ent to at least some degree in one specimen. Therefore, 
the lowest estimate for incidence of rejection, if one as-
sumes that rejection did not occur in those patients 
without specimens available for examination, is 35/95, 
or 370/0; the actual incidence is probably much greater. 
Recurrence of Primary Disease and Relationship to 
Rejection 
The possibility of recurrent disease following trans-
plantation is an important consideration in evaluating 
patients for the procedure. As mentioned, this study 
is limited to patients with pathology specimens, and 
Retransplant specimen from OL T 334, 48 days after transplantation 
after immunosuppressive therapy had been decreased secondary to 
CMV hepatitis similarly to that in b. Note the numerous CMV inclu· 
sions (arrows) and Infiltrate of the portal tracts involving portal vein 
(PV). The terminal hepatic (central) veins showed similar changes 
identical to those seen in rejection. (H&E, x 100; inset, x 450) 
... ----------------------
158 DEMETRIS ET AL AJP • January 1985 
Table 3-Specimen Diagnosis as a Function of Time After Transplantation 
Specimen 
Time after transplantation (weeks) 
diagnosis <1 1-2 2-4 4-8 
Rejection 1 5 6 8 
CMV /rejection 0 0 0 3 
Obstruction/Cholangitis 4 6 7 4 
Vascular insult 3 1 5 1 
Viral hepatitis (8) 0 0 0 0 
Herpes/CMV hepatitis 0 0 2 2 
Necrosis 0 0 2 2 
Functional cholestasis 2 4 2 0 
Nonspecific changes 9 5 0 
Total 19 21 24 21 
the follow-up period is relatively short. Therefore, no 
definitive conclusions can be drawn. The number of 
recurrences confirmed pathologically in patients with 
specific pretransplant disease is shown in Table 5. Only 
viral hepatitis B (2 cases at 4 and 10 months) both 
HBsAg and HBeAg positive at the time of transplan-
tation and the Budd-Chiari syndrome (1 case at 15 
months after transplantation) were noted to recur. 
No instances of recurrent primary biliary cirrhosis 
(PBC) were documented either clinically or histologi-
cally. The average period of follow-up in this unique 
group of patients was 10 months, the maximum being 
18 months. Recurrence of PBC following orthotopic 
liver transplantation has been previously reportedll in 
three patients whose features presented after 3 -years. 
Although the histologic appearance of rejection has 
been compared with that of PBC,4.5 no granulomas, 
lymphoid follicles, or increased deposition of copper-
associated proteins was seen in the cases of rejection 
observed in our patients whose original disease was 
PBC. Several of these patients had histologic evidence 
of bile ductular injury, but the histopathologic features 
were thought to be more representative of rejection than 
of recurrent PBC. 
Likewise, no definite conclusions on the relationship 
of rejection to pretransplant disease could be made (see 
Table 5). However, from the data available, it appears 
that no group (common pretransplant disease) is more 
likely to experience rejection than another. 
Discussion 
Rejection in the transplanted liver was not recognized 
histologically before 6-7 days. It is frequently seen 
within the first 2 months and is a common early cause 
of graft failure. Although this is markedly different from 
that reported earlier by Fennell, 6.10 many factors have 
evolved in hepatic transplantation 13 since that earlier 
report. These earlier reports6 • 10 were based largely on 
autopsy studies in whi<.:h the majority of patients 
8-12 12-26 26-52 >52 Total 
3 5 4 4 36 
0 0 0 0 3 
2 0 0 0 23 
3 0 0 14 
0 3 2· 6 
0 0 0 0 4 
0 1 0 0 5 
0 0 0 0 8 
0 2 19 
8 11 7 7 118 
reported suffered from infections and technical com-
plications. Since then, surgical techniques have im-
proved, decreasing the frequency of technical com-
plications; and cyclosporine· has replaced more 
conventional immunosuppressants, lowering the inci-
dence of infective complications. 13 Frequently autopsy 
specimens also have other complicating lesions and may 
not show rejection which was present days previously 
and treated with supplemental steroids. 
In early episodes (within the first two months) of re-
jection, the histologic appearance is very similar to that 
reported in excellent studies by Porter9 and may result 
in residual portal and central venous thickening. Later 
episodes of rejection may be severe and can occur at 
any time but are generally associated with a somewhat 
milder portal and/or lobular inflammatory infiltrate. 
Disruption of the limiting plate and bile ductular cell 
injury is more prevalent in these latter specimens. 
Repeated or ongoing rejection may lead to a decrease 
of interlobular bile ducts and portal fibrosis but rarely 
cirrhosis (one case). 
Early episodes of rejection may be confused with 
biliary obstruction and/or cholangitis,21-23 while those 
episodes occurring later are difficult to distinguish from 
Table 4-Cause of Graft Failure (Retransplantation) as a 
Function of Time After Transplantation 
Time after 
transplantation (weeks) 
Diagnosis 1-4 4-8 8-26 26-52 >52 Total 
Rejection 6 4 3' It 2t 16 
CMV /rejection 0 2 0 0 0 2 
Obstruction/cholangitis 0 0 0 0 5 
Vascular insult 3 0 0 0 0 3 
Total 14 6 3 2 26 
, Two-thirds of these patients had histologic changes identical to those 
described below. t 
t These cases represent those failures attributed to chronic vascular 
lesions and a paucity of interlobular bile ducts with a mild to moderate portal 
inflammatory infiltrate. 
!, 
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Table 5 - Pretransplant Disease: Recurrence and Relationship to Rejection 
Pretran sp lantat i on Number of Number experienc- Recurrence of Maximum follow-up 
djagnosls cases ing rejection primary disease- (months) 
Primary biliary cirrhosis 
Sclerosing cholangitis 
Nonalcoholic cirrhosis 
Alpha-1-antitrypsin deficiency 
Hepatitis B 
Budd-Chiari syndrome 
Hepatocellular carcinoma 
Cholangiolar carcinoma 
Caroli's disease 
Hepatic necrosis (toxin)§ 
Congenital biliary hypoplasia 
Secondary biliary cirrhosis 
Tyrosinemia/hepatoma 
Hemangiosarcoma 
Wilson's disease 
Total 
• Histologically documented. 
t See text. 
12 
12 
10 
5 
4 
3 
3 
3 
3 
2 
62 
10 ot 18 
6 o=!: 12 
8 0 72 
2 0 4 
2 2 15 
1 1 15 
2 0 6 
0 0 2 
0 144 
1 
0 0 2 
0 8 
0 0 7 
0 0 1 
0 2 
35 3 
=!: Four patients with preoperative biliary sepsis developed septic cholangitis postoperatively. 
§ Secondary to 2-nitropropane exposure." 
viral liver disease without knowledge of the clinical data. 
However, infiltration and disruption of the portal and 
central venous endothelium, prominent bile ductular 
cell injury, imrnunoperoxidase studies, and various clin-
ical parameters are helpful distinguishing features of 
rejection in such cases. 
The arterial lesions of rejection may be an impor-
tant factor in graft failure and are similar to those de-
scribed in heart and kidney grafts_ 2.4,.15 These lesions are 
most evident in medium-sized arteries, which are not 
well represented in biopsies. Previous studies2 ,9,10 based 
on human material have equated the vascular lesions 
with the presence of subendothelial foam cells, which 
was the most common finding in this study in such 
cases. However, as illustrated above, a spectrum of ar-
terial changes may be seen similar to those reported by 
Porter9 in experimental animals. Moreover, because the 
evaluation of the arterioles is subjective in needle bi-
opsy specimens, such biopsies, may not be a particu-
larly good method for the evaluation of these vascular 
lesions. 
Separation of hepatic rejection into acute and chronic 
forms may be by convention and somewhat artificial, 
because any of the lesions attributed to rejection may 
occur at any time after transplantation. Nevertheless, the 
more acute lesions are usually seen within the first 2 
months, although, as mentioned they may be seen any-
time thereafter. The chronic arterial lesions and loss of 
small interlobular bile ductules associated with a mild 
to moderate portal infiltrate appears to be a gradual and 
more indolent or chronic process, somewhat resistant to 
maintenance immunosuppressive therapy. In many spec-
imens, however, both were present simultaneously. 
The lowest estimate for the incidence of hepatic re-
jection after transplantation was determined to be 37070_ 
Although the actual incidence is probably significantly 
higher, these findings are appreciably different from 
those reported by Fennel and Roddy6 and Roddy et al. 10 
As shown in this study, hepatitis B may occur in trans-
planted livers either as acute or chronic disease. Although 
no marker(s) for non-A, non-B (NANB) hepatitis exists, 
some of the cases in the present study and other reports ' 
with "chronic active liver disease" following transplanta-
tion may be attributable to this agent(s), rather than re-
jection_ Although a prompt clinical response to sup-
plemental steroids may be indicative of rejection in such 
cases, we cannot be certain that NANB hepatitis may 
not do likewise. Herpes simplex and CMV hepatitis can 
also be a cause of graft dysfunction. The histologic ap-
pearance of herpes simplex and the less severe form of 
CMV hepatitis is similar to that reported in non-liver-
allograft patients. 2 6-28 However, the deterioration of 
graft function with a transition from the less to more 
severe CMV hepatitis after a decrease in immunosup-
pressive therapy is an interesting initial observation. 
Whether the deterioration is due to 1) CMV alone be-
cause of delayed effects of immunosuppression and/or 
2) enhanced viral replication29 •3o secondary to a simul-
taneous acute rejection episode is uncertain. However, 
both clinically and histologically, coexistent rejection 
appears to have been a significant factor in these two 
cases. The suggestion of a relationship between an ex-
acerbation of CMV infection and allograft rejection 
episodes has been raised for other organ recipients. 31 
Pathologically documented recurrent primary dis-
orders observed in this study included type B viral hep-
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atitis and the Budd-Chiari syndrome. No cases of recur-
rent primary biliary cirrhosis were seen on the basis of 
our clinicopathologic analysis. It should be noted, how-
ever, that the length of our follow-up is much less than 
that reported by Neuberger. 11 
One study based on needle biopsies 1 showed that 
bile ductular injury was not a component of rejectiori, 
as opposed to other earlier studies. 3-5 Small bile duc-
tular injury was observed in our specimens and, al-
though not prominent in early episodes, was more 
prevalent in later specimens (see Table 1). The process 
is focal, however, and is therefore better appreciated in 
transplant and autopsy specimens than it is in needle 
biopsies. This fact may account for some of the reported 
discrepancies. Differences in surgical technique, treat-
ment protocol, and immunosuppressive agents may also 
be important factors. Although ductular damage ap-
pears to be a part of the rejection process, and its rec-
ognition may be helpful in differentiating it from other 
complications, ductular injury should not be the sole 
criteria used to establish the diagnosis of rejection. 
Other disorders affecting the graft may also injure in-
terlobular bile ducts"· 23 ,32,33 and need to be considered 
as well. 
In this regard, the histologic appearance of rejection 
in the liver, particularly later than 2 months after trans-
plantation, has been compared with idiopathic autoim-
mune chronic active hepatitis,1.34 primary biliary cir-
rhosis,4,5,35 and chronic graft-versus-host-disease 
(GVHD).45,36 It is not surprising that many of the fea-
tures described for chronic GVHD36 are identical to 
those seen in rejection. We also noted, as reported in 
GVHD,37 that bile ductular cell injury, although pres-
ent in earlier specimens (less than 2 months), is more 
prevalent in later specimens (greater than 2 months). 
The cellular injury mediated by T-Iymphocytes in 
GVHD appears to be selective for ductal epithelium,38 
which may ,be related to expression of Ia antigens on 
target cells that normally do not express the antigen. 39 
A similar phenonemen may occur in hepatic rejection40 
and may be also related to the preferential expression 
of Class I and II HLA antigens on endothelial, 
reticuloendothelial, and bile ductule cells. 41 
Although much has yet to be learned concerning the 
identification and pathogenesis of the histologic lesions 
that occur in these patients, the liver biopsy frequently 
is of significant value in forming treatment plans. How-
ever, in some cases, the histopathologic findings can 
only provide a differential diagnosis, which may only 
be fully resoluble with the availability of complete clin-
ical data. When no definitive conclusions can be drawn 
based on histologic study alone, communication be-
tween the clinician and the pathologist, preferably with 
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a select interest in liver pathology, is necessary for pro-
vision of optimal care to the transplant patient. 
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